[Monoclonal antibody-defined tumor marker CA19-9: evaluation of its clinical usefulness, using the radioimmunometric assay for CA19-9].
D000231:Adenocarcinoma, Papillary / Q000276:immunology*; D000293:Adolescent; D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000276:immunology*; D000951:Antigens, Neoplasm / Q000032:analysis*; D015295:Antigens, Tumor-Associated, Carbohydrate; D006801:Humans; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000276:immunology*; D011863:Radioimmunoassay
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate